Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.
about
PIK3CA mutation is associated with poor survival among patients with metastatic colorectal cancer following anti-EGFR monoclonal antibody therapy: a meta-analysis.The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)Prognostic role of tumor PIK3CA mutation in colorectal cancer: a systematic review and meta-analysisReporting tumor molecular heterogeneity in histopathological diagnosis.EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximabDNA markers in molecular diagnostics for hepatocellular carcinoma.Targeted therapies in colorectal cancer-an integrative view by PPPMAnti-epidermal growth factor receptor monoclonal antibody-based therapy for metastatic colorectal cancer: a meta-analysis of the effect of PIK3CA mutations in KRAS wild-type patients.Overexpression of MET is a new predictive marker for anti-EGFR therapy in metastatic colorectal cancer with wild-type KRAS.Cetuximab: a guide to its use in combination with FOLFIRI in the first-line treatment of metastatic colorectal cancer in the USA.Functions and Regulation of the PTEN Gene in Colorectal Cancer.No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC).Promising therapeutics of gastrointestinal cancers in clinical trials.Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology.Molecular Biomarkers for the Evaluation of Colorectal Cancer.PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
P2860
Q27852105-D096D79E-4CAE-43BA-B267-261856263616Q27852988-ADCDA7DD-D18D-4627-860D-29845830D3B8Q28541078-62231170-2266-4533-9C45-6A4C025246A8Q30248900-A509CACC-AAE4-4035-963B-21B09BC4B9AEQ34050798-456E2FD1-94A4-4CE5-8C95-AADB11A5086FQ35042323-2CD013DB-1DFD-470B-A372-F67ADC017245Q35781255-EF4F5AE7-EA70-4F9D-9FA2-1F9DAEB0FFC8Q36646911-E091F328-6857-4E81-83F6-98511409C65DQ37636844-9D172410-D8C2-4DC9-B5CE-8B7573B75FF0Q37663252-DF518931-52EC-488A-8328-6FB86EB9EBE8Q38051281-160FA1E5-7D52-4CAF-B98F-0E83FBAE2EEDQ38182985-B087E0A1-6443-41A1-9AFA-8A321FDC14E7Q39154481-5F5D2A87-5204-4577-AD56-F25A4313AE65Q39453620-2F28E677-33A7-435E-A910-0B0304EC5163Q40341349-DF83513C-0D3B-466F-97A0-F0BD86A21CCFQ52794464-D8D591FF-E2DA-4528-A866-AD25B7C6D917Q54393310-2DBE09F3-C174-4B6B-82F6-6A12F725F4C2
P2860
Predictive role of multiple gene alterations in response to cetuximab in metastatic colorectal cancer: a single center study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Predictive role of multiple ge ...... cancer: a single center study.
@ast
Predictive role of multiple ge ...... cancer: a single center study.
@en
type
label
Predictive role of multiple ge ...... cancer: a single center study.
@ast
Predictive role of multiple ge ...... cancer: a single center study.
@en
prefLabel
Predictive role of multiple ge ...... cancer: a single center study.
@ast
Predictive role of multiple ge ...... cancer: a single center study.
@en
P2093
P2860
P50
P356
P1476
Predictive role of multiple ge ...... cancer: a single center study
@en
P2093
Angela Ragazzini
Dino Amadori
Giovanni Luca Frassineti
Laura Capelli
Luca Saragoni
Martina Valgiusti
Paola Rosetti
Wainer Zoli
P2860
P2888
P356
10.1186/1479-5876-10-87
P50
P577
2012-05-08T00:00:00Z
P5875
P6179
1032490077